CN Stock MarketDetailed Quotes
688319 Chengdu Olymvax Biopharmaceuticals Inc
- 10.99
- -0.01-0.09%
Market Closed Dec 27 15:00 CST
4.46BMarket Cap-523.33P/E (TTM)
11.18High10.90Low29.41KlotVolume11.13Open11.00Pre Close32.38MTurnover0.73%Turnover Ratio255.58P/E (Static)405.93MShares16.0652wk High4.90P/B4.46BFloat Cap7.0252wk Low13.20Limit Up405.41MShs Float48.62Historical High8.80Limit Down2.55%Amplitude7.02Historical Low0.04Dividend TTM11.01Avg Price17.52KlotAsk0.35%Div YieldTTM100Lot Size11.21KlotBid
Chengdu Olymvax Biopharmaceuticals Inc Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 9.75%386.65M | -2.97%226.28M | 5.87%70.8M | -9.38%496.12M | -4.98%352.3M | 0.21%233.2M | 24.91%66.87M | 12.38%547.48M | 30.20%370.78M | 37.60%232.71M |
| Operating revenue | 9.75%386.65M | -2.97%226.28M | 5.87%70.8M | -9.38%496.12M | -4.98%352.3M | 0.21%233.2M | 24.91%66.87M | 12.38%547.48M | 30.20%370.78M | 37.60%232.71M |
| Total operating cost | 15.50%379.82M | 24.47%244.5M | 71.43%109.13M | -5.24%490.85M | 4.16%328.85M | 5.47%196.44M | 3.41%63.66M | 34.39%517.97M | 48.28%315.7M | 47.24%186.25M |
| Operating cost | -18.54%20.43M | -24.15%12.3M | -25.14%5.36M | -18.09%32M | -7.78%25.07M | -7.07%16.22M | 146.53%7.16M | 32.05%39.06M | 28.02%27.19M | 41.80%17.45M |
| Operating tax surcharges | 6.43%2.23M | -4.17%1.6M | 3.60%402.43K | -6.41%3.32M | -6.08%2.09M | 1.31%1.67M | 17.89%388.44K | 10.67%3.55M | 23.76%2.23M | 23.15%1.65M |
| Operating expense | 15.55%185.24M | 0.52%102.82M | -14.35%23.92M | -10.61%257.81M | -5.07%160.31M | -0.98%102.29M | 1.71%27.93M | 17.47%288.39M | 38.38%168.87M | 55.23%103.3M |
| Administration expense | 8.40%63.04M | 41.57%46.87M | 231.47%29.43M | 23.01%78.31M | 25.85%58.16M | 5.23%33.11M | -37.30%8.88M | 25.26%63.66M | 33.74%46.21M | 35.94%31.47M |
| Financial expense | 223.52%9.48M | 255.47%5.62M | 247.42%2.28M | 257.23%4.68M | 181.32%2.93M | 89.18%1.58M | 98.56%655.18K | 2,286.90%1.31M | 3,793.86%1.04M | 90.11%835.37K |
| -Interest expense (Financial expense) | 128.58%10.38M | 122.95%6.37M | 98.94%2.79M | 69.24%7.18M | 42.10%4.54M | 72.74%2.86M | 127.33%1.4M | 246.16%4.24M | 343.03%3.2M | 156.71%1.66M |
| -Interest Income (Financial expense) | 42.84%-1.1M | 40.07%-902.99K | 34.04%-514.64K | 33.60%-2.55M | 24.18%-1.93M | -46.96%-1.51M | -103.61%-780.19K | -170.59%-3.85M | -162.13%-2.54M | -235.38%-1.03M |
| Research and development | 23.82%99.4M | 81.12%75.29M | 155.99%47.74M | -5.95%114.73M | 14.42%80.28M | 31.76%41.57M | 13.89%18.65M | 116.45%121.99M | 110.61%70.16M | 38.90%31.55M |
| Credit Impairment Loss | -69.54%-15.59M | -30.49%-21.91M | -35.33%2.64M | 87.10%-1.59M | 18.85%-9.2M | -11.87%-16.79M | 184.21%4.08M | -35.89%-12.3M | -65.41%-11.33M | -89.03%-15.01M |
| Asset Impairment Loss | 124.08%5.07M | 304.13%5.41M | 236.42%6.23M | -19.96%-4.73M | 1,586.33%2.26M | 198.06%1.34M | -1,579.30%-4.57M | -421.91%-3.94M | -95.86%134.28K | -144.78%-1.37M |
| Other net revenue | ||||||||||
| Invest income | -50.80%500.63K | -72.25%178.89K | -97.11%18.66K | -71.85%1.04M | -70.93%1.02M | -81.17%644.73K | 77.54%644.73K | -1.68%3.7M | 512.21%3.5M | 3,866.82%3.42M |
| Asset deal income | ---- | ---- | ---- | -1.70%-149.54K | -1.70%-149.54K | -46.41%-149.83K | ---- | -206.88%-147.05K | ---147.05K | ---102.34K |
| Other revenue | 36.85%3.7M | 503.97%2.81M | 161.89%1.13M | -86.88%3.25M | 494.84%2.71M | -44.20%464.79K | 136.85%431.11K | 525.31%24.8M | -86.75%454.86K | -63.75%833.02K |
| Operating profit | -97.41%519.95K | -242.56%-31.74M | -845.36%-28.31M | -92.55%3.1M | -57.86%20.1M | -34.95%22.27M | 160.13%3.8M | -59.03%41.62M | -34.00%47.68M | -14.67%34.23M |
| Add:Non operating Income | -89.35%1.04M | -88.43%1.04M | 556,245.58%1.04M | 389.51%12.55M | 247.11%9.8M | 292.68%9M | -99.57%186.79 | -54.47%2.56M | -48.07%2.82M | 2.52%2.29M |
| Less:Non operating expense | 406.63%116.87K | -16.22%16.76K | --24.44K | -93.96%32.12K | -95.66%23.07K | -96.24%20K | ---- | 2,177.18%531.69K | 4,329.58%531.69K | 16,719,742.77%531.69K |
| Total profit | -95.16%1.45M | -198.31%-30.72M | -818.61%-27.3M | -64.22%15.62M | -40.22%29.88M | -13.18%31.25M | 155.82%3.8M | -59.28%43.65M | -35.66%49.98M | -15.02%35.99M |
| Less:Income tax cost | -59.99%1.53M | ---- | ---- | -75.54%4.18M | -60.98%3.82M | -2.97%4.8M | --1.45M | 2,306.64%17.07M | --9.8M | --4.95M |
| Net profit | -100.32%-82.91K | -216.16%-30.72M | -1,262.25%-27.3M | -56.95%11.44M | -35.16%26.05M | -14.81%26.44M | 134.51%2.35M | -75.38%26.58M | -48.27%40.18M | -26.71%31.04M |
| Net profit from continuing operation | -100.32%-82.91K | -216.16%-30.72M | -1,262.25%-27.3M | -56.95%11.44M | -35.16%26.05M | -14.81%26.44M | 134.51%2.35M | -75.38%26.58M | -48.27%40.18M | -26.71%31.04M |
| Less:Minority Profit | 2.90%-4.11M | -31.92%-2.77M | 13.70%-1.3M | ---6.11M | ---4.23M | ---2.1M | ---1.51M | ---- | ---- | ---- |
| Net profit of parent company owners | -86.71%4.03M | -197.90%-27.95M | -774.61%-26M | -33.94%17.56M | -24.62%30.28M | -8.04%28.55M | 156.63%3.85M | -75.38%26.58M | -48.27%40.18M | -26.71%31.04M |
| Earning per share | ||||||||||
| Basic earning per share | -86.75%0.0099 | -197.87%-0.0689 | -774.74%-0.0641 | -33.99%0.0433 | -24.62%0.0747 | -8.09%0.0704 | 156.55%0.0095 | -76.60%0.0656 | -51.73%0.0991 | -34.02%0.0766 |
| Diluted earning per share | -86.75%0.0099 | -197.87%-0.0689 | -774.74%-0.0641 | -33.99%0.0433 | -24.62%0.0747 | -8.09%0.0704 | 156.55%0.0095 | -76.60%0.0656 | -51.73%0.0991 | -34.02%0.0766 |
| Other composite income | ||||||||||
| Total composite income | -100.32%-82.91K | -216.16%-30.72M | -1,262.25%-27.3M | -56.95%11.44M | -35.16%26.05M | -14.81%26.44M | 134.51%2.35M | -75.38%26.58M | -48.27%40.18M | -26.71%31.04M |
| Total composite income of parent company owners | -86.71%4.03M | -197.90%-27.95M | -774.61%-26M | -33.94%17.56M | -24.62%30.28M | -8.04%28.55M | 156.63%3.85M | -75.38%26.58M | -48.27%40.18M | --31.04M |
| Total composite income of minority owners | 2.90%-4.11M | -31.92%-2.77M | 13.70%-1.3M | ---6.11M | ---4.23M | ---2.1M | ---1.51M | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
